Copyright
©2013 Baishideng. All rights reserved.
World J Clin Cases. May 16, 2013; 1(2): 87-91
Published online May 16, 2013. doi: 10.12998/wjcc.v1.i2.87
Published online May 16, 2013. doi: 10.12998/wjcc.v1.i2.87
Synchronous rectal and esophageal cancer treated with chemotherapy followed by two-stage resection
Setsuo Utsunomiya, Takuya Kurimoto, Department of Gastrointestinal Oncology, Nagoya Kyoritsu Hospital, Nakagawa-ku, Nagoya 454-0933, Japan
Keisuke Uehara, Masahide Fukaya, Yu Takahashi, Yoshiro Taguchi, Keita Itatsu, Masato Nagino, Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya 466-8550, Japan
Ken Hirose, Department of Gastroenterology, Nagoya Kyoritsu Hospital, Nakagawa-ku, Nagoya 454-0933, Japan
Author contributions: Uehara K and Utsunomiya S designed the report; Utsunomiya S and Taguchi Y were attending doctors for the patients; Uehara K, Fukaya M, Takahashi Y and Itatsu K performed surgical operation; Kurimoto T and Hirose K were performed image diagnosis; Nagino M and Uehara K organized the report; and Utsunomiya S wrote paper.
Correspondence to: Keisuke Uehara, MD, PhD, Division of Surgical Oncology, Department of Surgery, Nagoya Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. kuehara@med.nagoya-u.ac.jp
Telephone: +81-52-7442222 Fax: +81-52-7442230
Received: February 10, 2013
Revised: April 3, 2013
Accepted: April 10, 2013
Published online: May 16, 2013
Revised: April 3, 2013
Accepted: April 10, 2013
Published online: May 16, 2013
Core Tip
Core tip: In case with synchronous multiple cancers, it is sometimes difficult to identify the origin especially when liver and/or pulmonary lesions have a possibility of metastases, or to decide on a course or priority of the treatment. FOLFOX + cetuximab (Cet) therapy could provide a favorable control of not only rectal origin accompanied by liver metastases but also esophageal cancer, which made possible to undergo two-stage curative resection. FOLFOX + Cet regimen might be a useful option for such refractory rectal and esophageal cancer.